These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11042752)

  • 1. Low rate of seropositivity to poliovirus among teenagers in Myanmar: A potential pocket for polio.
    Kojima K; Urasawa S; Aung TS; Khine A; Thu HM
    JAMA; 2000 Oct; 284(16):2058. PubMed ID: 11042752
    [No Abstract]   [Full Text] [Related]  

  • 2. Progress toward poliomyelitis eradication--Myanmar, 1996-1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Oct; 48(42):967-71. PubMed ID: 10553811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The final stages of the global eradication of polio.
    John TJ
    N Engl J Med; 2000 Sep; 343(11):806-7. PubMed ID: 10984572
    [No Abstract]   [Full Text] [Related]  

  • 4. Infectious disease. Polio eradication effort adds new weapon to its armory.
    Roberts L
    Science; 2005 Jan; 307(5707):190. PubMed ID: 15653472
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidemiological serosurvey of poliovirus in Guangdong, China: A cross-sectional study.
    Tan Q; Zhu Q; Zheng H; Zhang B; Wu C; Guo X; Li H; Liu L; Liu Y; Rutherford S; Zheng H
    Hum Vaccin Immunother; 2018; 14(11):2644-2648. PubMed ID: 30059644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study evaluating poliovirus antibodies and risk factors associated with polio seropositivity in low socioeconomic areas of Pakistan.
    Habib M; Soofi S; Ali N; Sutter RW; Palansch M; Qureshi H; Akhtar T; Molodecky NA; Okayasu H; Bhutta ZA
    Vaccine; 2013 Apr; 31(15):1987-93. PubMed ID: 23429005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Need for polio boosters after age two years.
    Rennels MB
    Vaccine; 2009 Jan; 27(2):179-80. PubMed ID: 19007837
    [No Abstract]   [Full Text] [Related]  

  • 8. Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States.
    Chen RT; Hausinger S; Dajani AS; Hanfling M; Baughman AL; Pallansch MA; Patriarca PA
    JAMA; 1996 Jun; 275(21):1639-45. PubMed ID: 8637136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A seroprevalence study of poliovirus antibody in the population of northern Greece.
    Frantzidou F; Diza E; Halkia D; Antoniadis A
    Clin Microbiol Infect; 2005 Jan; 11(1):68-71. PubMed ID: 15649308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A comparison of the effectiveness of mass immunization campaign of trivalent oral poliovirus vaccine (TOPV) by epidemiological serosurvey. Shandong Collaborating Group for Poliomyelitis Control and Surveillance, Jinan, Shandong].
    Xu A
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):261-4. PubMed ID: 1338626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A seroprevalence study of poliovirus antibody against a collection of recombinant and non-recombinant poliovirus vaccine strains in the population of southern Greece.
    Pliaka V; Ruether IG; Kyriakopoulou Z; Kioussi P; Plakokefalos E; Megalou M; Pratti A; Levidiotou-Stefanou S; Markoulatos P
    Clin Microbiol Infect; 2010 Nov; 16(11):1672-5. PubMed ID: 20148919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2001 serological survey in the Czech Republic--poliomyelitis.
    Matyásová I; Rainetová P; Cástková J
    Cent Eur J Public Health; 2003 Dec; 11 Suppl():S31-5. PubMed ID: 15080257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A seroepidemiological study of polio in Thailand and investigation of the OPV (oral polio vaccine) immunization].
    Yamada M
    Nihon Ika Daigaku Zasshi; 1985 Feb; 52(1):20-38. PubMed ID: 2982909
    [No Abstract]   [Full Text] [Related]  

  • 14. [Collective poliomyelitis immunity in the adult population and its impact on eradication of this infection].
    Seĭbil' VB; Malyshkina LP; Lavrova IK; Efimova VF
    Vopr Virusol; 2007; 52(3):44-7. PubMed ID: 17601053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paralytic poliomyelitis during the pre-, peri- and post-suspension periods of a polio immunization campaign.
    Lamina S; Hanif S
    Trop Doct; 2008 Jul; 38(3):173-5. PubMed ID: 18628551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polio vaccines: WHO position paper – March, 2016.
    Wkly Epidemiol Rec; 2016 Mar; 91(12):145-68. PubMed ID: 27039410
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preventive poliomyelitis immunization].
    Böthig B
    Z Arztl Fortbild (Jena); 1990; 84(8):365-7. PubMed ID: 2165712
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunity against poliomyelitis in the Netherlands, assessed in 2006 to 2007: the importance of completing a vaccination series.
    van der Maas NA; Mollema L; Berbers GA; van Rooijen DM; van der Avoort HG; Conyn-Van Spaendonck MA; de Melker HE; van der Klis FR
    Euro Surveill; 2014 Feb; 19(7):20705. PubMed ID: 24576472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological analysis of immunity to poliovirus after termination of an era of vaccination with OPV in Germany. An analysis of the German Association Against Viral Diseases (DVV).
    Franck S; Allwinn R; Rabenau HF; Doerr HW
    Zentralbl Bakteriol; 1999 Oct; 289(4):475-81. PubMed ID: 10603664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WHO policy statement on polio vaccines.
    Wkly Epidemiol Rec; 1995 Dec; 70(49):346-7. PubMed ID: 8652353
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.